The London International Invention & Trade Expo, recognised globally as a benchmark for scientific and technological innovation and previously awarded to leading companies including Novartis and Bayer, has honoured Bionique with a Gold Medal for its breakthrough women’s health product — Bionique FEMBIOTIC Women’s Probiotics Complex. The product has also been distinguished with a Gold Medal at the Prix Eiffel International Invention and Innovation Contest, further underscoring its innovative leadership in women’s microbime science.
As awareness of women’s microbiome health grows worldwide, maintaining the balance of vaginal and gut flora has become a central focus in preventive healthcare. Studies indicate that over 70% of women experience microbiome imbalance at some point in their lives — a figure continuing to rise across the Asia-Pacific region due to lifestyle, environmental, and stress-related factors.
The award-winning Bionique FEMBIOTIC formula features the company’s proprietary strain of Lactobacillus crispatus— BIO-01, combined with seven clinically validated Lactobacillus strains and postbiotics within the proprietary Biometrica™ Complex. Clinical data have demonstrated measurable improvements in key women’s health indicators, including:
- 77.78% reduction in vaginitis incidence
- 57.78% decrease in HPV viral load
- 41.67% improvement in endometrial health
In a category-first innovation, Swiss Apple Stem Cell–derived Exosomes have been incorporated into the formulation. Peer-reviewed studies published in Aging and Frontiers in Endocrinology highlight the exosomes’ ability to promote mucosal repair, tissue regeneration, and hydration. By combining exosome technology with targeted probiotics, Bionique delivers a dual-action solution addressing both microbiome balance and mucosal integrity.
“Our focus extends beyond probiotic supplementation — it’s about restoring the full microecological system and reinforcing the body’s natural barriers,” said Bionique’s Head of R&D. “This recognition from both the London Expo and the Prix Eiffel Contest reaffirms our commitment to evidence-based, science-driven innovation.”
With its TGA listing confirmed (ARTG No: 518206) along with international recognition, Bionique FEMBIOTIC Women’s Probiotics Complex is setting a new standard for women’s microbiome health — leading Australia’s next wave of innovation in probiotic science and precision health solutions.
Available at: https://bioeorganic.com.au/products/bionique-fembiotic-women-s-probiotic-complex
Media Contact
Company Name: Bio-E Australia Pty. Ltd.
Contact Person: Louise Edmonds
Email: Send Email
Country: Australia
Website: www.bioeorganic.com.au